Literature DB >> 20164253

Identification of and human serum reactogenicity to neutralizing epitopes within the central unglycosylated region of the respiratory syncytial virus attachment protein.

Yoshihiko Murata1, Paula M Lightfoote, Ann R Falsey, Edward E Walsh.   

Abstract

We identified two overlapping neutralizing epitopes within residues 151 to 172 of the central unglycosylated region of the respiratory syncytial virus (RSV) attachment protein. In approximately 40% of hospitalized and outpatient adults infected with RSV subtype A, these contiguous residues are the target of > or =4-fold increases in IgG response between acute- and convalescent-phase sera.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20164253      PMCID： PMC2849351          DOI： 10.1128/CVI.00432-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  16 in total

1.  Type-specific serologic diagnosis of respiratory syncytial virus infection, based on a synthetic peptide of the attachment protein G.

Authors:  J P Langedijk; W G Middel; W M Schaaper; R H Meloen; J A Kramps; A H Brandenburg; J T van Oirschot
Journal:  J Immunol Methods       Date:  1996-06-21       Impact factor: 2.303

2.  The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.

Authors:  P R Johnson; M K Spriggs; R A Olmsted; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins.

Authors:  E E Walsh; C B Hall; J J Schlesinger; M W Brandriss; S Hildreth; P Paradiso
Journal:  J Gen Virol       Date:  1989-11       Impact factor: 3.891

4.  The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity.

Authors:  C Palomo; B García-Barreno; C Peñas; J A Melero
Journal:  J Gen Virol       Date:  1991-03       Impact factor: 3.891

5.  Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.

Authors:  J J Gorman; J L McKimm-Breschkin; R S Norton; K J Barnham
Journal:  J Biol Chem       Date:  2001-08-03       Impact factor: 5.157

6.  Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus.

Authors:  P A Cane
Journal:  J Med Virol       Date:  1997-04       Impact factor: 2.327

7.  Antigenic structure of the central conserved region of protein G of bovine respiratory syncytial virus.

Authors:  J P Langedijk; R H Meloen; G Taylor; J M Furze; J T van Oirschot
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

8.  Analysis of the human serological immune response to a variable region of the attachment (G) protein of respiratory syncytial virus during primary infection.

Authors:  P A Cane; H M Thomas; A F Simpson; J E Evans; C A Hart; C R Pringle
Journal:  J Med Virol       Date:  1996-03       Impact factor: 2.327

9.  Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus.

Authors:  E Norrby; M A Mufson; H Alexander; R A Houghten; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

10.  Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.

Authors:  Joshua J Shinoff; Katherine L O'Brien; Bhagvanji Thumar; Jana B Shaw; Raymond Reid; Wei Hua; Mathuram Santosham; Ruth A Karron
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226
View more
  9 in total

1.  Deep sequencing of RSV from an adult challenge study and from naturally infected infants reveals heterogeneous diversification dynamics.

Authors:  Jessica W Lau; Young-In Kim; Ryan Murphy; Ruchi Newman; Xiao Yang; Michael Zody; John DeVincenzo; Yonatan H Grad
Journal:  Virology       Date:  2017-08-03       Impact factor: 3.616

2.  Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice.

Authors:  Yoshihiko Murata; Seana C Catherman
Journal:  Vaccine       Date:  2012-06-19       Impact factor: 3.641

3.  Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.

Authors:  Fu-Shi Quan; Yonghwan Kim; Sujin Lee; Hong Yi; Sang-Moo Kang; Jadranka Bozja; Martin L Moore; Richard W Compans
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

4.  RSV recombinant candidate vaccine G1F/M2 with CpG as an adjuvant prevents vaccine-associated lung inflammation, which may be associated with the appropriate types of immune memory in spleens and lungs.

Authors:  Na Li; Ling Zhang; Boyang Zheng; Wenjian Li; Jianxun Liu; Huixian Zhang; Ruihong Zeng
Journal:  Hum Vaccin Immunother       Date:  2019-04-29       Impact factor: 3.452

5.  A study of the genetic variability of human respiratory syncytial virus (HRSV) in Cambodia reveals the existence of a new HRSV group B genotype.

Authors:  Alicia Arnott; Sirenda Vong; Sek Mardy; Simon Chu; Monica Naughtin; Ly Sovann; Carole Buecher; Julien Beauté; Sareth Rith; Laurence Borand; Nima Asgari; Roger Frutos; Bertrand Guillard; Sok Touch; Vincent Deubel; Philippe Buchy
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

6.  Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein.

Authors:  Yoshihiko Murata; Paula M Lightfoote; Jamie N Biear; Ann R Falsey; Edward E Walsh
Journal:  Vaccine       Date:  2010-07-23       Impact factor: 3.641

7.  Influence of respiratory syncytial virus strain differences on pathogenesis and immunity.

Authors:  José A Melero; Martin L Moore
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

8.  Molecular epidemiology and evolution of human respiratory syncytial virus and human metapneumovirus.

Authors:  Eleanor R Gaunt; Rogier R Jansen; Yong Poovorawan; Kate E Templeton; Geoffrey L Toms; Peter Simmonds
Journal:  PLoS One       Date:  2011-03-01       Impact factor: 3.240

9.  The Complexity of Antibody Responses Elicited against the Respiratory Syncytial Virus Glycoproteins in Hospitalized Children Younger than 2 Years.

Authors:  Alfonsina Trento; Rosa Rodríguez-Fernández; María I González-Sánchez; Felipe González-Martínez; Vicente Mas; Mónica Vázquez; Concepción Palomo; José A Melero
Journal:  Front Microbiol       Date:  2017-11-22       Impact factor: 5.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.